Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Algorithm-based Therapy for Staphylococcal Bacteremia
NCT01191840Phase 2Completed
- Sponsor
- Duke University
- Start
- Feb 2011
- Primary completion
- Mar 2017
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of vancomycin in staphylococcal bloodstream infection, sponsored by Duke University. Started Feb 2011; status: completed.
02
Drugs
vancomycin
03
Conditions
staphylococcal bloodstream infection
Beyond the preview
Go deeper on NCT01191840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01191840.